Clob 10 mg (Tablet)
Unit Price: ৳ 3.85 (10 x 10: ৳ 385.00)
Strip Price: ৳ 38.50
Medicine Details
Category | Details |
---|---|
Generic | Clobazam |
Company | Opsonin pharma ltd |
Indications
- Acute anxiety treatment
- Chronic anxiety treatment
- Sleep disturbances
- Emotional instability
- Adjunctive therapy for depression
- Adjunctive therapy for epilepsy
Pharmacology
Binds to GABA receptors in CNS, increases chloride ionopore opening time, enhances GABA inhibitory effect
Dosage
- Adults and adolescents over 15 years: Initial dose of 20mg daily, maximum daily dose of 30mg
- Elderly: Lower initial doses, maintenance dose of 10-15mg daily
- Children from 3 to 15 years: 5-10mg daily, careful assessment needed
- Duration of treatment: As short as possible, not exceeding 8 to 12 weeks, assessment after 4 weeks
Administration
- Can be administered whole or crushed
- Can be mixed in applesauce
- Can be taken with or without food
Interaction
- Alcohol: Increases bioavailability by 50%
- Central nervous system depressant drugs: Mutually potentiating effect
- Opioids: Increases risk of sedation and respiratory depression
- Anticonvulsants: Possible interactions with basic anticonvulsant medication
- CYP 2C19 inhibitors: May result in increased exposure to active metabolite
- CYP 2D6 substrates: Weak CYP2D6 inhibitor
Contraindications
- Hypersensitivity to clobazam or excipients
- Myasthenia gravis
- Severe respiratory insufficiency
- Sleep apnoea syndrome
- Severe hepatic impairment
- Breastfeeding
- Children between 6 months and 3 years
Side Effects
- Decreased appetite
- Irritability
- Somnolence
- Dizziness
- Dry mouth
- Rash
- Muscle weakness
- Fatigue
- Weight increase
Pregnancy & Lactation
- Pregnancy: Not recommended during first trimester, potential benefit justifies potential risk
- Lactation: Must not be used in breastfeeding women
Precautions & Warnings
- Serious Skin Reactions: Closely monitor for signs of SJS/TEN
- Respiratory depression: Monitor respiratory function, contraindicated in severe respiratory insufficiency
- Muscle weakness: Contraindicated in myasthenia gravis
- Renal and hepatic impairment: Increased responsiveness and susceptibility, regularly check function
- Elderly patients: Increased risk of adverse reactions, recommend dose reduction
- Tolerance in epilepsy: Consider possibility of tolerance development
- Suicidality: Reports of suicidal behavior, especially with confounding factors
- Concomitant use of CYP2C19 inhibitors: May result in increased exposure to active metabolite
Therapeutic Class
Benzodiazepine hypnotics
Storage Conditions
Store below 30°C, protect from light, keep out of reach of children